Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction - PubMed (original) (raw)
Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction
R Studer et al. J Clin Invest. 1994 Jul.
Abstract
Local activation of the components of the renin angiotensin system in the heart is regarded as an important modulator of cardiac phenotype and function; however, little is known about their presence, regulation, and potential activation in the human heart. To investigate the gene expression of major angiotensin-II-forming enzymes in left ventricles of normal (n = 9) and failing human hearts (n = 20), we established a competitive RNA-polymerase chain reaction (PCR) for mRNA quantification of angiotensin-I converting enzyme (ACE) and human heart chymase. For each gene, competitor RNA targets with small internal deletions were used as internal standards to quantify the original number of transcripts and to control reverse transcription and PCR. In PCR, each target and the corresponding competitor were amplified by competing for the same primer oligonucleotides. The variability of ACE RNA-PCR was 11% indicating a high reproducibility of this method. In addition, ACE mRNA levels obtained by competitive RNA-PCR correlated favorably with traditional slot blot hybridization (r = 0.69, n = 10; P < 0.05). Compared with nonfailing hearts, the number of ACE transcripts referred to 100 ng of total RNA was increased threefold in patients with chronic heart failure (4.2 +/- 2.5 vs. 12.8 +/- 6 x 10(5); P < 0.0005). In contrast, no significant difference was found in chymase gene expression between normal and failing hearts. Thus, the expression of the cardiac ACE but not of human heart chymase is upregulated in failing human heart indicating an activation of the cardiac renin-angiotensin system in patients with advanced heart failure.
Similar articles
- Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.
Batlle M, Roig E, Perez-Villa F, Lario S, Cejudo-Martin P, García-Pras E, Ortiz J, Roqué M, Orús J, Rigol M, Heras M, Ramírez J, Jimenez W. Batlle M, et al. J Heart Lung Transplant. 2006 Sep;25(9):1117-25. doi: 10.1016/j.healun.2006.04.012. Epub 2006 Aug 9. J Heart Lung Transplant. 2006. PMID: 16962475 - Co-expression of renin-angiotensin system component genes in human atrial tissue.
Morgan K, Wharton J, Webb JC, Keogh BE, Smith PL, Taylor KM, Oakley CM, Polak JM, Cleland JG. Morgan K, et al. J Hypertens Suppl. 1994 Jul;12(4):S11-9. J Hypertens Suppl. 1994. PMID: 7965269 - Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
Urata H, Ganten D. Urata H, et al. Eur Heart J. 1993 Nov;14 Suppl I:177-82. Eur Heart J. 1993. PMID: 8293772 Review. - Angiotensin I converting enzyme and chymase in cardiovascular tissues.
Nishimura H, Hoffmann S, Baltatu O, Sugimura K, Ganten D, Urata H. Nishimura H, et al. Kidney Int Suppl. 1996 Jun;55:S18-23. Kidney Int Suppl. 1996. PMID: 8743505 Review.
Cited by
- Angiotensin Converting Enzyme 1 Expression in the Leukocytes of Adults Aged 64 to 67 Years.
Bueno V, Destro PH, Teixeira D, Frasca D. Bueno V, et al. JMIRx Med. 2023 Jan 20;4:e45220. doi: 10.2196/45220. JMIRx Med. 2023. PMID: 37725526 Free PMC article. - The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart.
Abd Alla J, Quitterer U. Abd Alla J, et al. Cells. 2022 Feb 14;11(4):654. doi: 10.3390/cells11040654. Cells. 2022. PMID: 35203304 Free PMC article. Review. - ERK1/2: An Integrator of Signals That Alters Cardiac Homeostasis and Growth.
Gilbert CJ, Longenecker JZ, Accornero F. Gilbert CJ, et al. Biology (Basel). 2021 Apr 20;10(4):346. doi: 10.3390/biology10040346. Biology (Basel). 2021. PMID: 33923899 Free PMC article. Review. - ACE phenotyping in human heart.
Tikhomirova VE, Kost OA, Kryukova OV, Golukhova EZ, Bulaeva NI, Zholbaeva AZ, Bokeria LA, Garcia JGN, Danilov SM. Tikhomirova VE, et al. PLoS One. 2017 Aug 3;12(8):e0181976. doi: 10.1371/journal.pone.0181976. eCollection 2017. PLoS One. 2017. PMID: 28771512 Free PMC article. - Blunting of cardioprotective actions of estrogen in female rodent heart linked to altered expression of cardiac tissue chymase and ACE2.
da Silva JS, Gabriel-Costa D, Wang H, Ahmad S, Sun X, Varagic J, Sudo RT, Ferrario CM, Dell Italia LJ, Sudo GZ, Groban L. da Silva JS, et al. J Renin Angiotensin Aldosterone Syst. 2017 Jul-Sep;18(3):1470320317722270. doi: 10.1177/1470320317722270. J Renin Angiotensin Aldosterone Syst. 2017. PMID: 28748720 Free PMC article.
References
- J Biol Chem. 1984 Jan 10;259(1):224-30 - PubMed
- Lancet. 1993 Oct 30;342(8879):1073-5 - PubMed
- Science. 1984 Jul 20;225(4659):324-6 - PubMed
- Circ Res. 1985 Jul;57(1):84-95 - PubMed
- J Clin Invest. 1986 Jul;78(1):31-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous